Regadenoson .08 mg/mL (Regadenoson Anhydrous INJECTION, SOLUTION) .08 mg/mL

Regadenoson .08 mg/mL is an injectable solution used for pharmaceutical applications. This medication is designed to support specific medical procedures, ensuring reliable and effective results. Learn more about its uses and benefits.

Strength

.08 mg/mL

Pack Size

10 SYRINGE, PLASTIC in 1 BOX (0407-5034-05) / 5 mL in 1 SYRINGE, PLASTIC

Manufacturer / TM Owner

GE Healthcare

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Regadenoson .08 mg/mL is primarily used in medical settings to facilitate imaging of the heart. This solution is administered intravenously and is often utilized in procedures that require enhanced visibility of blood flow and heart function. What is Regadenoson used for? It is commonly employed in diagnostic imaging to assist healthcare professionals in assessing cardiac conditions.

Side Effects

When administered, Regadenoson .08 mg/mL may cause temporary increases in heart rate and blood pressure. These effects are generally short-lived and are part of the medication's mechanism of action. Patients may also experience flushing or headaches, which typically subside quickly.

Precautions & Warnings

Regadenoson .08 mg/mL should be handled with care and administered by trained healthcare professionals. It is important to follow proper storage and handling guidelines to maintain the integrity of the solution. Patients with certain medical conditions may need to be monitored closely during administration.

Avoid Interactions

Regadenoson .08 mg/mL may interact with other medications, particularly those that affect heart rate or blood pressure. It is advisable to inform healthcare providers about all current medications before administration. Additionally, caution should be exercised when combining Regadenoson with stimulants or other cardiovascular drugs.

Frequently Asked Questions

Regadenoson .08 mg/mL is used in medical imaging procedures to enhance the visibility of heart blood flow and function.

Regadenoson .08 mg/mL is administered intravenously by healthcare professionals in a clinical setting.

Common effects include temporary increases in heart rate and blood pressure, as well as possible flushing or headaches.

Yes, it should be administered by trained professionals and handled with care. Patients with certain conditions may need monitoring.

Yes, it may interact with medications that affect heart rate or blood pressure, so it's important to inform healthcare providers about all current medications.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.